Acorda Therapeutics (ACOR)

Acorda Therapeutics (ACOR) Income Statement


Acorda Therapeutics Income Statement

Last quarter (Q1 2023), Acorda Therapeutics's total revenue was $22.26M, a decrease of -1.22% from the same quarter last year. In Q1, Acorda Therapeutics's net income was $-16.82M. See Acorda Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 118.29M$ 118.57M$ 129.07M$ 152.97M$ 192.41M$ 471.43M
Cost of Revenue
$ 18.48M$ -30.33M$ 40.79M$ 33.51M$ 34.85M$ 97.64M
Gross Profit
$ 103.25M$ 100.79M$ 88.28M$ 119.45M$ 157.56M$ 373.79M
Operating Expense
$ 138.09M$ 142.82M$ 165.58M$ 206.35M$ 278.56M$ 280.31M
Operating Income
$ -34.85M$ -42.04M$ -77.30M$ -86.90M$ -121.01M$ 93.49M
Net Non Operating Interest Income Expense
$ -28.21M$ -28.29M$ -30.03M$ -29.76M$ -17.70M$ -18.08M
Other Income Expense
$ -15.37M$ -35.09M$ -1.75M$ 8.99M$ -135.54M$ -54.98M
Pretax Income
$ -29.84M$ -35.25M$ -109.07M$ -107.67M$ -274.25M$ 20.42M
Tax Provision
$ 28.37M$ 30.67M$ -5.12M$ -8.07M$ -1.28M$ -13.26M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -58.22M$ -65.92M$ -103.95M$ -99.59M$ -272.97M$ 33.68M
Basic EPS
$ -2.18$ -3.34$ -9.79$ -12.32$ -34.50$ 4.32
Diluted EPS
$ -2.18$ -3.34$ -9.79$ -12.32$ -34.50$ 4.26
Basic Average Shares
$ 85.12M$ 19.71M$ 10.62M$ 8.08M$ 7.92M$ 7.84M
Diluted Average Shares
$ 85.12M$ 19.71M$ 10.62M$ 8.08M$ 7.92M$ 7.89M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
$ -3.70-$ -6.31$ -54.12$ -10.32$ 13.20
Reported Normalized Diluted E P S
$ -3.70-$ -6.31$ -54.12$ -10.32$ 13.08
Rent Expense Supplemental
Total Expenses
$ 156.57M$ 112.49M$ 206.37M$ 239.86M$ 313.41M$ 377.95M
Net Income From Continuing And Discontinued Operation
$ -58.22M$ -65.92M$ -103.95M$ -99.59M$ -272.97M$ 33.68M
Normalized Income
$ -65.15M-$ -102.30M$ -107.75M$ -138.09M$ 73.83M
Interest Expense
$ 14.94M-$ 30.04M$ 30.57M$ 21.87M$ 21.60M
$ -1.60M$ -6.96M$ -79.04M$ -77.09M$ -252.38M$ 42.02M
$ 30.02M$ 23.81M$ -45.09M$ -35.80M$ -217.80M$ 53.50M
Currency in USD

Acorda Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis